828 related articles for article (PubMed ID: 15843445)
1. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
3. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.
Askling J; Klareskog L; Blomqvist P; Fored M; Feltelius N
Ann Rheum Dis; 2006 Sep; 65(9):1184-7. PubMed ID: 16414970
[TBL] [Abstract][Full Text] [Related]
4. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.
Hellgren K; Iliadou A; Rosenquist R; Feltelius N; Backlin C; Enblad G; Askling J; Baecklund E
Ann Rheum Dis; 2010 Apr; 69(4):654-9. PubMed ID: 19439429
[TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
7. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
Bahlas S; Ramos-Remus C; Davis P
J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
[TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
12. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
[TBL] [Abstract][Full Text] [Related]
13. [Polymyalgia rheumatica and temporal arteritis].
Vos PA; Bijlsma JW; Derksen RH
Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1932-7. PubMed ID: 16159030
[TBL] [Abstract][Full Text] [Related]
14. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
Uddhammar A; Eriksson AL; Nyström L; Stenling R; Rantapää-Dahlqvist S
J Rheumatol; 2002 Apr; 29(4):737-42. PubMed ID: 11950015
[TBL] [Abstract][Full Text] [Related]
15. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
Adizie T; Christidis D; Dharmapaliah C; Borg F; Dasgupta B
Int J Clin Pract; 2012 Sep; 66(9):906-9. PubMed ID: 22897467
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
18. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
[TBL] [Abstract][Full Text] [Related]
19. PMR and GCA: steroids or bust.
Adizie T; Dasgupta B
Int J Clin Pract; 2012 Jun; 66(6):524-7. PubMed ID: 22607502
[No Abstract] [Full Text] [Related]
20. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
Combe B; Sany J; Le Quellec A; Clot J; Eliaou JF
J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
